M A B Gama, U Tonmukayakul, N Saraswat, N McCaffrey, T M Nguyen
{"title":"Cost of Illness Study on Oral Cancer in Australia.","authors":"M A B Gama, U Tonmukayakul, N Saraswat, N McCaffrey, T M Nguyen","doi":"10.1111/odi.15267","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study is to estimate the economic burden of oral cancer in Australia from the societal perspective.</p><p><strong>Methods: </strong>The population consisted of the prevalence of lip and oral cavity cancer, and other lip, oral cavity, and pharynx cancers for ages 40 years and older. Healthcare costs of oral cancer were estimated using 2019-2020 Australian Disease Expenditure Data. Productivity losses were estimated using disability-adjusted life years, derived from the 2019 Global Burden of Disease Study and 2019 Australian gross domestic product per capita.</p><p><strong>Results: </strong>The estimated annual healthcare costs for oral cancer in Australia were approximately AUD$113.2 million. Over half of the total healthcare costs (54%) were attributable to public hospital admissions (AUD$61.2 million), followed by private hospital services (28%) and pharmaceutical benefits (8%). The total costs, including healthcare and productivity losses, were around AUD$2.1 billion. The productivity losses due to oral cancer were higher for males compared to females (AUD$1.5 billion versus AUD$0.6 billion).</p><p><strong>Conclusions: </strong>The study reveals a significant economic burden of oral cancer for 2019 in Australia at AUD$2.1 billion, largely due to productivity losses and public hospital admissions. This highlights the need for effective screening and prevention programs.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/odi.15267","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The aim of this study is to estimate the economic burden of oral cancer in Australia from the societal perspective.
Methods: The population consisted of the prevalence of lip and oral cavity cancer, and other lip, oral cavity, and pharynx cancers for ages 40 years and older. Healthcare costs of oral cancer were estimated using 2019-2020 Australian Disease Expenditure Data. Productivity losses were estimated using disability-adjusted life years, derived from the 2019 Global Burden of Disease Study and 2019 Australian gross domestic product per capita.
Results: The estimated annual healthcare costs for oral cancer in Australia were approximately AUD$113.2 million. Over half of the total healthcare costs (54%) were attributable to public hospital admissions (AUD$61.2 million), followed by private hospital services (28%) and pharmaceutical benefits (8%). The total costs, including healthcare and productivity losses, were around AUD$2.1 billion. The productivity losses due to oral cancer were higher for males compared to females (AUD$1.5 billion versus AUD$0.6 billion).
Conclusions: The study reveals a significant economic burden of oral cancer for 2019 in Australia at AUD$2.1 billion, largely due to productivity losses and public hospital admissions. This highlights the need for effective screening and prevention programs.
期刊介绍:
Oral Diseases is a multidisciplinary and international journal with a focus on head and neck disorders, edited by leaders in the field, Professor Giovanni Lodi (Editor-in-Chief, Milan, Italy), Professor Stefano Petti (Deputy Editor, Rome, Italy) and Associate Professor Gulshan Sunavala-Dossabhoy (Deputy Editor, Shreveport, LA, USA). The journal is pre-eminent in oral medicine. Oral Diseases specifically strives to link often-isolated areas of dentistry and medicine through broad-based scholarship that includes well-designed and controlled clinical research, analytical epidemiology, and the translation of basic science in pre-clinical studies. The journal typically publishes articles relevant to many related medical specialties including especially dermatology, gastroenterology, hematology, immunology, infectious diseases, neuropsychiatry, oncology and otolaryngology. The essential requirement is that all submitted research is hypothesis-driven, with significant positive and negative results both welcomed. Equal publication emphasis is placed on etiology, pathogenesis, diagnosis, prevention and treatment.